ArticlePharmaceutics2023

Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance.

Mohamed S Attia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.